approval the Office may specify additional conditions which apply to such investor contact and the securities company which has submitted the application for approval. In case the Office declines to grant
issue at each time. Authority to specify other details The Board of Directors or the person assigned by the Board of Directors are authorized as follows: 1. Specify various details related to the
prescribe details, conditions and/or terms in order to execute the relevant agreement(s) within April 2019, such as share sale and purchase agreement with respect to the Sale Shares, S-TREK shareholders
Company and the Seller shall further determine and prescribe details, conditions and/or terms in order to execute the relevant agreement(s) within April 2019, such as share sale and purchase agreement with
2019 (the “MOU”), having details as appeared in Clause 3.3 of this information memorandum. In this regard, the Company and the Seller shall further determine and prescribe details, conditions and/or
year at least the policy and indicated the concerned risks, arrangement the importance of information and computer system, specify the acceptable level of risk and specify measure or practice for risk
assessment once a year at least the policy and indicated the concerned risks, arrangement the importance of information and computer system, specify the acceptable level of risk and specify measure or practice
applicant seeking an approval to act as a mutual fund manager possesses any prohibited characteristics under Clause 4(9), (10), (11), (12), (13), (14), (15), (16), (17) or (18), the Office may specify a
an approval to act as a mutual fund manager possesses any prohibited characteristics under Clause 4(9), (10), (11), (12), (13), (14), (15), (16), (17) or (18), the Office may specify a period of time